Fortrea Holdings Inc. - Common Stock · Transaction Jun 23, 2025 · Filed Jul 24, 2025 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · FTRE
-1.71% · -$0.3500 · Vol 3.1M
Market closed · last close 4:00 PM ET · price as of 16:29:34 ET
Fortrea Holdings Inc
Life Sciences Tools & Services
$19.93
Follow $FTRE
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $FTRE by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredFri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET · FTRE
MethodologyFTRE
Fortrea Holdings Inc
Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
81/ 100
Veridion Score
Upper range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Fri Sep 18 · last completed session · Markets closed · resumes Mon 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is FTRE moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Fortrea Holdings Inc
SERVICES-MEDICAL LABORATORIESListed since
2023
Employees
14K
Country
US
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$20.10
Day high
$20.22
Day low
$19.28
Previous close
$20.28
52W high
$20.70
-3.71% from high
52W low
$8.40
94% of range
Market cap
$1.9B
EPS
$-4.7000
Beta
0.52
Shares out
95.1M
Volume
3.1M
2.30× rel vol
Avg volume
1.4M
VWAP
$19.82
Price history computed in-house
1W
+15.89%
1M
+8.39%
3M
+28.10%
1Y
+96.77%
YTD
+15.55%
SMA 50 $18.45 · above
SMA 200 $14.93 · above
52W position 94%
FTRE overview
Related filings and maps
Public disclosures
Congress activity in FTRE
Official filing ↗
Federal contracts
FTRE contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FTRE in this window.
Lobbying spend
FTRE lobbying filings, year to date.
Registered lobbying filings matched to Fortrea Holdings Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for FTRE in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for FTRE.
Options
Sovereign unlock shows live options positioning for FTRE.